NCT03836560

Brief Summary

The prevalence of cigarette smoking has dropped to 10% in Hong Kong (HK) in 2017, however, smoking still kills 5700 persons per year. Studies suggest that abstinence rates are higher with combined NRT than single NRT, although local data on safety and benefits of combined NRT are lacking. This is a one-year, two-arm, parallel randomized trial in 20 HK public clinics. The aim is to compare the effectiveness of combined NRT with single NRT among HK Chinese. 560 chronic smokers, who smoked ≥10 cigarettes/day for ≥ 1 year, were randomized to either intervention or usual care. Intervention group received counseling and nicotine patch \& gum. Usual care group received counselling and nicotine patch only. Primary outcome was smoking abstinence rate at 52 weeks. Secondary outcomes included smoking abstinence rate at 4, 12, \& 26 weeks. Crude odds ratio (combined NRT vs. single NRT) and p-value were reported from logistic regression without adjustment; for trend analysis, adjusted odds ratio (AOR) and p-value were reported from Generalized Estimating Equation (GEE) (controlling for time). All AORs were adjusted for age, sex, baseline CO and clusters.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
560

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2012

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2012

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 30, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 11, 2019

Completed
Last Updated

February 11, 2019

Status Verified

February 1, 2019

Enrollment Period

5.2 years

First QC Date

January 30, 2019

Last Update Submit

February 7, 2019

Conditions

Keywords

nicotine replacement therapysmoking cessationquit rates

Outcome Measures

Primary Outcomes (1)

  • 7-day point-prevalence abstinence rate at 52 weeks after quit date

    During initial assessment, patient will set a quit date with the counsellor. At 52 weeks after the quit rate, counsellor will call the patient and confirm his quit status. The status was confirmed by self reporting abstinence rate and exhaled carbon monoxide level

    at 52 weeks after the agreed quit date

Secondary Outcomes (2)

  • side effects profiles

    up to 1 year

  • 7-day point-prevalence of abstinence rate at 26 weeks after quit date

    at 26 weeks after the agreed quit date

Study Arms (2)

Usual group

ACTIVE COMPARATOR

Usual group with nicotine patch only: Usual care involved counseling and 8 weeks of single NRT of nicotine patch. For those smoking 20 or more cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 21mg patches, then 2 weeks of 14mg patches, followed by 2 weeks of 7mg patches. For those smoking 10 to 19 cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 14mg patches, followed by 4 weeks of 7mg patches.

Drug: Nicotine patch

Intervention group

ACTIVE COMPARATOR

Nicotine patch and nicotine gum: Intervention consisted of counseling and 8 weeks of combined NRT of nicotine patch and gum. For those smoking 20 or more cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 21mg patches, then 2 weeks of 14mg patches, followed by 2 weeks of 7mg patches. For those smoking 10 to 19 cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 14mg patches, followed by 4 weeks of 7mg patches. 2mg nicotine gum was used once every 1 to 2 hours when required.

Drug: Nicotine patchDrug: Nicotine gum

Interventions

nicotine patch given for 8 weeks

Intervention groupUsual group

nicotine gum given as requested

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • current smokers who smoke 10 or more cigarettes a day for at least one year

You may not qualify if:

  • unstable angina
  • severe cardiac arrhythmia
  • recent acute myocardial infarction or cerebrovascular accident in preceding 3 months
  • below 18 years old
  • being pregnant or on breast-feeding
  • unable to use gum
  • with a previous history of failure to NRT
  • with a history of hypersensitivity to nicotine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Theodoulou A, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J, Livingstone-Banks J, Hajizadeh A, Lindson N. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2023 Jun 19;6(6):CD013308. doi: 10.1002/14651858.CD013308.pub2.

  • Leung MKW, Bai D, Yip BHK, Fong MY, Lai PMH, Lai P, Lai ISY, Lam ZHW, Leung ATF, To DKY, Wong MT, Wong TK, Chao DVK. Combined nicotine patch with gum versus nicotine patch alone in smoking cessation in Hong Kong primary care clinics: a randomised controlled trial. BMC Public Health. 2019 Oct 16;19(1):1302. doi: 10.1186/s12889-019-7634-z.

MeSH Terms

Conditions

Smoking Cessation

Interventions

Tobacco Use Cessation DevicesNicotine Chewing Gum

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Intervention Hierarchy (Ancestors)

TherapeuticsChewing GumPlant GumsBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesCandyFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • David Chao, FHKAM

    Hospital Authority

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor did not know which arm was interventional/control during the data analysis process.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: One year, 2 arm, parallel, randomised controlled trial
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant in Family Medicine

Study Record Dates

First Submitted

January 30, 2019

First Posted

February 11, 2019

Study Start

December 18, 2012

Primary Completion

February 28, 2018

Study Completion

February 28, 2018

Last Updated

February 11, 2019

Record last verified: 2019-02